Artivion (AORT) Competitors

Artivion (NYSE:AORT) and Axonics (NASDAQ:AXNX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment, community ranking and analyst recommendations.

Does the MarketBeat Community favor AORT or AXNX?

Axonics received 152 more outperform votes than Artivion when rated by MarketBeat users. However, 78.57% of users gave Artivion an outperform vote while only 66.41% of users gave Axonics an outperform vote.

Company	Underperform	Outperform
Artivion	Outperform Votes 22 78.57%	Underperform Votes 6 21.43%
Axonics	Outperform Votes 174 66.41%	Underperform Votes 88 33.59%

Is AORT or AXNX more profitable?

Artivion has a net margin of -0.22% compared to Axonics' net margin of -1.31%. Artivion's return on equity of 5.15% beat Axonics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	-0.22%	5.15%	1.91%
Axonics	-1.31%	0.36%	0.31%

Do analysts rate AORT or AXNX?

Artivion currently has a consensus target price of $31.00, indicating a potential upside of 14.14%. Axonics has a consensus target price of $71.00, indicating a potential upside of 0.03%. Given Artivion's stronger consensus rating and higher probable upside, analysts plainly believe Artivion is more favorable than Axonics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Axonics	0 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media favor AORT or AXNX?

In the previous week, Axonics had 6 more articles in the media than Artivion. MarketBeat recorded 7 mentions for Axonics and 1 mentions for Artivion. Artivion's average media sentiment score of 1.76 beat Axonics' score of 0.91 indicating that Artivion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Axonics	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in AORT or AXNX?

86.4% of Artivion shares are held by institutional investors. Comparatively, 99.5% of Axonics shares are held by institutional investors. 8.1% of Artivion shares are held by insiders. Comparatively, 1.9% of Axonics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility & risk, AORT or AXNX?

Artivion has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Axonics has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.

Which has preferable valuation and earnings, AORT or AXNX?

Axonics has higher revenue and earnings than Artivion. Artivion is trading at a lower price-to-earnings ratio than Axonics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$354M	3.22	-$30.69M	-$0.02	-1,358.00
Axonics	$366.38M	9.90	-$6.09M	-$0.12	-591.45

Summary

Artivion beats Axonics on 11 of the 18 factors compared between the two stocks.